Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936)

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 6, 2004, Pages 2179-2184

  Hirata, Takahiro ^a,b   Saito, Asami ^a   Nishino, Kunihiko ^a,b,c   Tamura, Norihisa ^a,b   Yamaguchi, Akihito ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACRAB PROTEIN; ACREF PROTEIN; BACTERIAL PROTEIN; DOXYCYCLINE; ETHIDIUM BROMIDE; MINOCYCLINE; MULTIDRUG EFFLUX PROTEIN; TET EFFLUX RESISTANCE DETERMINANT PROTEIN; TET EFFLUX TRANSPORTER PROTEIN; TET(B) PROTEIN; TETR REPRESSOR PROTEIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG;

ACRAB GENE; ACREF GENE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BCR GENE; DRUG MECHANISM; ESCHERICHIA COLI; ESCHERICHIA COLI KAM3; GENE EXPRESSION; MEMBRANE VESICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTON TRANSPORT; TET(B) GENE; TET(C) GENE; TET(K) GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL MEMBRANE; ESCHERICHIA COLI; ETHIDIUM; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMIDS; PROTONS; QUINACRINE; TETRACYCLINE RESISTANCE; TETRACYCLINES;

EID: 2542444502     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.6.2179-2184.2004     Document Type: Article

References (34)

1. Abbanat, D., M. Macielag, and K. Bush. 2003. Novel antibacterial agents for the treatment of serious gram-positive infections. Expert Opin. Investig. Drugs 12:379-399.
2. Bryskier, A. 1999. Novelties in the field of anti-infectives in 1998. Clin. Infect. Dis. 29:632-658.
3. Chopra, I. 2001. Glycylcyclines: third-generation tetracycline antibiotics. Curr. Opin. Pharmacol. 1:464-469.
4. Chopra, I. 2002. New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors. Drug Resist. Update 5:119-125.
5. Chopra, I., and M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232-260.
6. Dean, C. R., M. A. Visalli, S. J. Projan, P. E. Sum, and P. A. Bradford. 2003. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob. Agents Chemother. 47:972-978.
7. Fujihira, E., N. Tamura, and A. Yamaguchi. 2002. Membrane topology of a multidrug efflux transporter, AcrB, in Escherichia coli. J. Biochem. (Tokyo) 131:145-151.
8. + antiporter of Staphylococcus aureus. FEBS Lett. 412:337-340.
9. Kaneko, M., A. Yamaguchi, and T. Sawai. 1985. Energetics of tetracycline efflux system encoded by Tn10 in Escherichia coli. FEBS Lett. 193:194-198.
10. Lewinson, O., J. Adler, G. J. Poelarends, P. Mazurkiewicz, A. J. Driessen, and E. Bibi. 2003. The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions. Proc. Natl. Acad. Sci. USA 100:1667-1672.
11. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
12. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55.
13. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1993. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175:6299-6313.
14. McMurry, L., R. E. Petrucci, Jr., and S. B. Levy. 1980. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. USA 77:3974-3977.
15. Morita, Y., K. Kodama, S. Shlota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1998. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42:1778-1782.
16. Murakami, S., R. Nakashima, E. Yamashita, and A. Yamaguchi. 2002. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587-593.
17. Nishino, K., and A. Yamaguchi. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183:5803-5812.
18. Noguchi, N., A. Emura, M. Sasatsu, and M. Kono. 1994. Expression in Escherichia coli of a TetK determinant from Staphylococcus aureus. Biol. Pharm. Bull. 17:352-355.
19. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
20. Petersen, P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
21. Ramos, J. L., E. Duque, M. T. Gallegos, P. Godoy, M. L. Ramos-Gonzalez, A. Rojas, W. Teran, and A. Segura. 2002. Mechanisms of solvent tolerance in gram-negative bacteria. Annu. Rev. Microbiol. 56:743-768.
22. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. + antiporter. Antimicrob. Agents Chemother. 39:247-249.
24. Sutcliffe, J. G. 1979. Complete nucleotide sequence of the Escherichia coli plasmid pBR322. Cold Spring Harbor Symp. Quant. Biol. 43:77-90.
25. Taylor, J. W., J. Ott, and F. Eckstein. 1985. The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA. Nucleic Acids Res. 13:8765-8785.
26. Tuckman, M., P. J. Petersen, and S. J. Projan. 2000. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines. Microb. Drug Resist. 6:277-282.
27. Van Bambeke, F., Y. Glupczynski, P. Plesiat, J. C. Pechere, and P. M. Tulkens. 2003. Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J. Antimicrob. Chemother. 51:1055-1065.
28. Visalli, M. A., E. Murphy, S. J. Projan, and P. A. Bradford. 2003. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother. 47:665-669.
29. + translocation. J. Biol. Chem. 266:6045-6051.
30. Yamaguchi, A., K. Adachi, and T. Sawai. 1990. Orientation of the carboxyl terminus of the transposon Tn10-encoded tetracycline resistance protein in Escherichia coli. FEBS Lett. 265:17-19.
31. + antiporter encoded by transposon Tn10 of Escherichia coli. Biochemistry 31:8344-8348.
32. + antiporter of Escherichia coli encoded by a transposon, Tn10. The role of the conserved dipeptide, Ser65-Asp66, in tetracycline transport. J. Biol. Chem. 265:15525-15530.
33. + antiporter. FEBS Lett. 365:193-197.
34. Yamamoto, T., M. Tanaka, C. Nohara, Y. Fukunaga, and S. Yamagishi. 1981. Transposition of the oxacillin-hydrolyzing penicillinase gene. J. Bacteriol. 145:808-813.